| Shareholder | |||
|---|---|---|---|
| Chan Yu Ling, AbrahamExecutive Director | 59.66% | 319.71M | |
| Man Yee Wai, ViolaExecutive Director | 59.66% | 319.71M | |
| Providence Discovery Fund | 8.68% | 46.51M | |
| Protoss Global Opportunities Fund | 7.62% | 40.82M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of PURAPHARM (01498) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

